News
Yosprala Launched for Secondary Prevention of CV Events in Ulcer-Risk Patients
Yosprala combines aspirin, an antiplatelet, and omeprazole, a proton pump inhibitor.
Your search for proton pump inhibitor returned 27 results
News
Proton Pump Inhibitor Use May Up Death Risk
The authors found that compared to the use of H2RA therapy, patients initiated on PPI therapy had a 25% increased risk of death (hazard ratio [HR] 1.25, 95% CI: 1.23-1.28).
News
Do PPIs Protect Against Dysplasia, Cancer in Barrett’s Esophagus?
In patients with Barrett's esophagus, use of proton pump inhibitors (PPIs) did not lead to dysplasia- or cancer-protective effects.
News
FDA Expands Dexilant Use for Younger GERD Patients
Takeda announced that the Food and Drug Administration (FDA) has approved Dexilant (dexlansoprazole) delayed-release capsules and Dexilant SoluTab delayed-release orally-disintegrating tablets for patients aged 12-17 years with gastroesophageal reflux disease (GERD).
News
Some Antacids Linked to Heart Attack Risk
Use of proton pump inhibitors (PPIs) increase the risk of an adult experiencing a heart attack by 16 to 21 percent compared to those who don't use commonly prescribed antacids, a large study has found.
News
Myopathy: Another Side Effect of PPIs?
Limited research published in Annals of Pharmacotherapy suggests that use of proton pump inhibitors (PPI) is associated with myopathy-like symptoms without long-term effects after discontinuation.
Generics News
Dr. Reddy’s Launches Generic Nexium
Dr. Reddy's Laboratories announced the launch of Esomeprazole Magnesium Delayed-Release Capsules, the generic version of AstraZeneca's Nexium Delayed-Release Capsules.
Generics News
FDA Approves First Generic Nexium
The Food and Drug Administration (FDA) has approved Ivax Pharmaceutical's Esomeprazole Magnesium Delayed-Release Capsules, the first generic version of AstraZeneca's Nexium.
Generics News
Teva Launches Generic Nexium
Teva announced the launch of Esomeprazole Magnesium Delayed-Release Capsules, the generic version of AstraZeneca's Nexium.
News
Study Examines PPI Benefit in Warfarin-Related GI Bleeding
Co-treatment with proton-pump inhibitors (PPIs) in patients initiating warfarin was associated with reduced reduced risk of warfarin-related upper gastrointestinal (GI) bleeding, a study published in Gastroenterology reported.
